Ami Fadia
Stock Analyst at Needham
(3.99)
# 588
Out of 4,981 analysts
385
Total ratings
47.56%
Success rate
12.13%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Maintains: Buy | $56 → $66 | $46.55 | +41.78% | 26 | Sep 11, 2025 | |
| BIIB Biogen | Reiterates: Hold | n/a | $144.86 | - | 42 | Sep 4, 2025 | |
| JAZZ Jazz Pharmaceuticals | Reiterates: Buy | $202 | $126.16 | +60.11% | 34 | Aug 28, 2025 | |
| IMRX Immuneering | Reiterates: Buy | $8 | $8.49 | -5.77% | 18 | Aug 26, 2025 | |
| MRUS Merus | Maintains: Buy | $97 → $96 | $69.53 | +38.07% | 30 | Aug 6, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $18 → $16 | $7.12 | +124.72% | 21 | Aug 6, 2025 | |
| AXSM Axsome Therapeutics | Reiterates: Buy | $150 | $118.42 | +26.67% | 16 | Aug 4, 2025 | |
| ALKS Alkermes | Reiterates: Buy | $45 | $26.97 | +66.85% | 3 | Jul 29, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $30 | $23.61 | +27.06% | 10 | Jun 26, 2025 | |
| COGT Cogent Biosciences | Reiterates: Hold | n/a | $12.66 | - | 23 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $37.71 | +112.17% | 12 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $21.81 | +60.48% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.62 | +208.64% | 9 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $15.40 | +23.38% | 36 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $32.39 | +51.28% | 37 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $139 | $141.90 | -2.04% | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $7.05 | +311.35% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $240 → $320 | $15.01 | +2,031.91% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $63 → $75 | $27.12 | +176.55% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $15 → $23 | $0.68 | +3,196.70% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $63 | $22.27 | +182.89% | 5 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $12 → $5 | $5.63 | -11.11% | 2 | Jan 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $19.93 | - | 9 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $1.26 | +1,646.03% | 4 | Jan 3, 2018 |
Revolution Medicines
Sep 11, 2025
Maintains: Buy
Price Target: $56 → $66
Current: $46.55
Upside: +41.78%
Biogen
Sep 4, 2025
Reiterates: Hold
Price Target: n/a
Current: $144.86
Upside: -
Jazz Pharmaceuticals
Aug 28, 2025
Reiterates: Buy
Price Target: $202
Current: $126.16
Upside: +60.11%
Immuneering
Aug 26, 2025
Reiterates: Buy
Price Target: $8
Current: $8.49
Upside: -5.77%
Merus
Aug 6, 2025
Maintains: Buy
Price Target: $97 → $96
Current: $69.53
Upside: +38.07%
Day One Biopharmaceuticals
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $16
Current: $7.12
Upside: +124.72%
Axsome Therapeutics
Aug 4, 2025
Reiterates: Buy
Price Target: $150
Current: $118.42
Upside: +26.67%
Alkermes
Jul 29, 2025
Reiterates: Buy
Price Target: $45
Current: $26.97
Upside: +66.85%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $30
Current: $23.61
Upside: +27.06%
Cogent Biosciences
Jun 17, 2025
Reiterates: Hold
Price Target: n/a
Current: $12.66
Upside: -
Jun 12, 2025
Reiterates: Buy
Price Target: $80
Current: $37.71
Upside: +112.17%
May 28, 2025
Initiates: Buy
Price Target: $35
Current: $21.81
Upside: +60.48%
May 13, 2025
Reiterates: Buy
Price Target: $5
Current: $1.62
Upside: +208.64%
May 8, 2025
Reiterates: Buy
Price Target: $19
Current: $15.40
Upside: +23.38%
May 7, 2025
Reiterates: Buy
Price Target: $49
Current: $32.39
Upside: +51.28%
May 6, 2025
Maintains: Buy
Price Target: $138 → $139
Current: $141.90
Upside: -2.04%
May 2, 2025
Reiterates: Buy
Price Target: $29
Current: $7.05
Upside: +311.35%
Feb 1, 2021
Maintains: Outperform
Price Target: $240 → $320
Current: $15.01
Upside: +2,031.91%
Jan 21, 2021
Downgrades: Market Perform
Price Target: $63 → $75
Current: $27.12
Upside: +176.55%
Oct 1, 2020
Maintains: Market Perform
Price Target: $15 → $23
Current: $0.68
Upside: +3,196.70%
Sep 17, 2020
Maintains: Outperform
Price Target: $64 → $63
Current: $22.27
Upside: +182.89%
Jan 30, 2019
Downgrades: Market Perform
Price Target: $12 → $5
Current: $5.63
Upside: -11.11%
Oct 1, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $19.93
Upside: -
Jan 3, 2018
Initiates: Outperform
Price Target: $22
Current: $1.26
Upside: +1,646.03%